...
首页> 外文期刊>Surgical laparoscopy, endoscopy and percutaneous techniques >Prevention of adhesions by bioresorbable tissue barrier following laparoscopic intraabdominal mesh insertion.
【24h】

Prevention of adhesions by bioresorbable tissue barrier following laparoscopic intraabdominal mesh insertion.

机译:腹腔镜腹腔内网状插入后通过生物可吸收组织屏障防止粘连。

获取原文
获取原文并翻译 | 示例
           

摘要

Intraabdominal adhesions represent a significant problem because of the morbidity associated with adhesive disease, including small bowel obstruction, difficulties in reoperative surgery, and possibly chronic pain. Coating solution of sodium hyaluronate (Sepracoat; Genzyme Production-Surgical Products, Cambridge, MA) was studied in New Zealand white rabbits to determine its potential role for prevention of postoperative adhesions following laparoscopic intraabdominal mesh insertion. A 2-cm polypropylene mesh was inserted laparoscopically to the left iliac fossa and fixed to anterior abdominal wall using a single prolen suture. Group 1 (n = 10) acted as the control group. Mesh was coated using 4% sodium hyaluronate in phosphate buffered saline (Sepracoat) in Group 2 (n = 10). Fourteen days later, all animals underwent diagnostic laparoscopy, and findings were recorded. All animals then were killed, the abdominal cavities were inspected, and adhesions were graded from 0 to 4. All meshes were removed and sent for histologic examination. The degrees of inflammation, fibrosis, and congestion were scored. No adhesions were seen on trocar sites on both groups. Eight of 10 animals in the control group and 5 of 10 animals in the study group had intraabdominal adhesions. The scoring of adhesions revealed that study group had only one (10%) significant adhesion, whereas the control group had eight (80%; < 0.001). Our study suggests that the Sepracoat reduces the incidence and severity of abdominal adhesions following laparoscopic mesh insertion and should be considered as a prophylactic agent, especially in those undergoing laparoscopic transabdominal mesh repair for hernia.
机译:腹内粘连代表了一个重大问题,因为与粘膜疾病相关的发病率包括小肠梗阻,手术困难以及可能的慢性疼痛。在新西兰白兔中研究了透明质酸钠的涂层溶液(Sepracoat; Genzyme Production-Surgical Products,剑桥,马萨诸塞州),以确定其在预防腹腔镜腹腔内网孔插入术后粘连中的潜在作用。腹腔镜下将2厘米聚丙烯筛网插入左to窝,并使用单缝缝合线将其固定到腹前壁。第1组(n = 10)充当对照组。在第2组(n = 10)中,用在磷酸盐缓冲盐水(Sepracoat)中的4%透明质酸钠涂覆网。 14天后,对所有动物进行诊断性腹腔镜检查,并记录发现。然后杀死所有动物,检查腹腔,并将粘连度从0分级到4级。取下所有网孔并送去进行组织学检查。对炎症,纤维化和充血程度进行评分。两组在套管针部位均未见粘连。对照组的10只动物中有8只,研究组的10只动物中有5只具有腹腔粘连。粘连评分显示,研究组只有一个(10%)显着粘连,而对照组有八个(80%; <0.001)。我们的研究表明,Sepracoat可以降低腹腔镜网孔插入后腹部粘连的发生率和严重程度,应被视为预防剂,尤其是在进行腹腔镜经腹网疝修补术的患者中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号